Bahman Yousefi Selected Research

Bahman Yousefi Research Topics

Disease

108	Neoplasms (Cancer) 09/2022 - 03/2014
16	Osteosarcoma (Osteogenic Sarcoma) 09/2022 - 11/2020
15	Inflammation (Inflammations) 01/2022 - 02/2017
14	Breast Neoplasms (Breast Cancer) 04/2021 - 09/2014
13	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2018
12	Carcinogenesis 07/2022 - 01/2019
12	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2015
5	COVID-19 04/2022 - 08/2020
5	Leukemia 01/2022 - 01/2015
5	Genomic Instability 01/2022 - 11/2018
5	Infections 07/2020 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 09/2014
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 02/2019
4	Ischemia 01/2021 - 06/2014
4	Rheumatoid Arthritis 12/2019 - 03/2013
4	Colonic Neoplasms (Colon Cancer) 10/2019 - 01/2014
3	Cytokine Release Syndrome 08/2022 - 12/2020
3	Type 2 Diabetes Mellitus (MODY) 04/2022 - 12/2017
3	Hemolysis 01/2022 - 01/2019
3	Hypoxia (Hypoxemia) 05/2020 - 03/2018
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 01/2015
3	Hepatocellular Carcinoma (Hepatoma) 02/2018 - 01/2012
3	Myocardial Reperfusion Injury 02/2017 - 06/2014
2	Disseminated Intravascular Coagulation 08/2022 - 01/2021
2	Insulin Resistance 04/2022 - 01/2019
2	Diabetes Complications 04/2022 - 11/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2020
2	Pathologic Processes 01/2022 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2019
2	Glioma (Gliomas) 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 11/2021 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 05/2017
2	Virus Diseases (Viral Diseases) 09/2021 - 01/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2021 - 02/2019

Drug/Important Bio-Agent (IBA)

22	MicroRNAs (MicroRNA)IBA 04/2022 - 11/2016
17	Proteins (Proteins, Gene)FDA Link 04/2022 - 03/2014
14	MelatoninIBA 07/2022 - 08/2017
10	Biological ProductsIBA 04/2022 - 01/2015
10	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 03/2014
9	QuercetinIBA 09/2022 - 01/2018
9	Pharmaceutical PreparationsIBA 07/2022 - 01/2016
9	AntioxidantsIBA 10/2021 - 01/2015
9	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021 - 10/2017
8	PolyphenolsIBA 09/2022 - 10/2019
8	EnzymesIBA 03/2022 - 03/2013
8	ChitosanIBA 01/2022 - 05/2020
7	Interleukin-6 (Interleukin 6)IBA 08/2022 - 06/2014
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2019
7	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2019 - 04/2013
6	Methotrexate (Mexate)FDA LinkGeneric 09/2022 - 01/2019
6	Antineoplastic Agents (Antineoplastics)IBA 06/2022 - 01/2016
6	CateninsIBA 04/2022 - 01/2017
5	CurcuminIBA 04/2022 - 02/2021
5	PhytochemicalsIBA 04/2022 - 01/2020
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 10/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2017
5	LipidsIBA 01/2020 - 03/2013
4	thymoquinoneIBA 09/2022 - 10/2021
4	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 03/2022
4	FlavonoidsIBA 09/2022 - 01/2018
4	Circular RNAIBA 07/2022 - 01/2020
4	LigandsIBA 05/2022 - 01/2016
4	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2019
4	Phosphotransferases (Kinase)IBA 11/2021 - 01/2012
4	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2022 - 02/2017
3	CytokinesIBA 08/2022 - 12/2019
3	Therapeutic UsesIBA 04/2022 - 07/2020
3	ResveratrolIBA 01/2022 - 01/2015
3	Long Noncoding RNAIBA 11/2021 - 01/2021
3	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 03/2021 - 01/2020
3	Dimenhydrinate (DMH)FDA LinkGeneric 03/2021 - 01/2020
3	SurvivinIBA 01/2021 - 09/2014
3	Small Interfering RNA (siRNA)IBA 01/2021 - 10/2018
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2020 - 01/2019
3	CarbohydratesIBA 12/2020 - 03/2020
3	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2020 - 01/2020
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 12/2017
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2018 - 03/2016
2	Dacarbazine (DIC)FDA LinkGeneric 08/2022 - 01/2021
2	NucleotidesIBA 04/2022 - 09/2020
2	Oxygen (Dioxygen)IBA 04/2022 - 03/2018
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 10/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 03/2019
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 03/2019
2	Free RadicalsIBA 01/2022 - 11/2018
2	InterleukinsIBA 01/2022 - 02/2017
2	Polysaccharides (Glycans)IBA 01/2022 - 03/2020
2	BerberineIBA 01/2022 - 04/2020
2	Vitamin D FDA LinkGeneric 09/2021 - 09/2014
2	Hormones (Hormone)IBA 06/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 10/2020 - 05/2017
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2020 - 05/2017
2	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 01/2020
2	Cytotoxins (Cytolysins)IBA 08/2020 - 02/2019

Therapy/Procedure

53	Therapeutics 09/2022 - 03/2014
27	Drug Therapy (Chemotherapy) 07/2022 - 01/2015
9	Radiotherapy 01/2022 - 03/2018
3	Immunotherapy 11/2020 - 02/2019